Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Fischer

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Organic & Biomolecular Chemistry|April 24, 2004
A fluorine scan of the phenylamidinium needle of tricyclic thrombin inhibitors: effects of fluorine substitution on pKa and binding affinity and evidence for intermolecular C-F...CN interactionsJacob Olsen, Paul Seiler, Björn Wagner, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2009
Imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepines as potent and highly selective GABAA alpha5 inverse agonists with potential for the treatment of cognitive dysfunctionBernd Buettelmann, Theresa M Ballard, Rodolfo Gasser, et al.
Therapeutic Advances in Drug Safety|August 2, 2014
Increased levels of urinary phenylacetylglycine associated with mitochondrial toxicity in a model of drug-induced phospholipidosisLucette Doessegger, Georg Schmitt, Barbara Lenz, et al.
Drug Discovery Today|January 25, 2012
Can we discover pharmacological promiscuity early in the drug discovery process?Jens-Uwe Peters, Jérôme Hert, Caterina Bissantz, et al.
Chembiochem : a European Journal of Chemical Biology|September 7, 2019
Modulation of Pharmacologically Relevant Properties of Piperidine Derivatives by Functional Groups in an Equatorial or Axial β-Position to the Amino GroupPatrick Schnider, Cosimo Dolente, Henri Stalder, et al.
Nature Reviews. Drug Discovery|July 31, 2010
Coexistence of passive and carrier-mediated processes in drug transportKiyohiko Sugano, Manfred Kansy, Per Artursson, et al.
BMC Cancer|July 15, 2015
Prospective cohort study using the breast cancer spheroid model as a predictor for response to neoadjuvant therapy--the SpheroNEO studyKathrin Halfter, Nina Ditsch, Hans-Christian Kolberg, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitorsEmmanuel Pinard, Daniela Alberati, Edilio Borroni, et al.
Drug Discovery Today|April 18, 2012
Evidence-based approach to assess passive diffusion and carrier-mediated drug transportLi Di, Per Artursson, Alex Avdeef, et al.
Bioorganic & Medicinal Chemistry Letters|September 19, 2009
The discovery and unique pharmacological profile of RO4938581 and RO4882224 as potent and selective GABAA alpha5 inverse agonists for the treatment of cognitive dysfunctionHenner Knust, Guido Achermann, Theresa Ballard, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Organic & Biomolecular Chemistry|April 24, 2004
A fluorine scan of the phenylamidinium needle of tricyclic thrombin inhibitors: effects of fluorine substitution on pKa and binding affinity and evidence for intermolecular C-F...CN interactionsJacob Olsen, Paul Seiler, Björn Wagner, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2009
Imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepines as potent and highly selective GABAA alpha5 inverse agonists with potential for the treatment of cognitive dysfunctionBernd Buettelmann, Theresa M Ballard, Rodolfo Gasser, et al.
Therapeutic Advances in Drug Safety|August 2, 2014
Increased levels of urinary phenylacetylglycine associated with mitochondrial toxicity in a model of drug-induced phospholipidosisLucette Doessegger, Georg Schmitt, Barbara Lenz, et al.
Drug Discovery Today|January 25, 2012
Can we discover pharmacological promiscuity early in the drug discovery process?Jens-Uwe Peters, Jérôme Hert, Caterina Bissantz, et al.
Chembiochem : a European Journal of Chemical Biology|September 7, 2019
Modulation of Pharmacologically Relevant Properties of Piperidine Derivatives by Functional Groups in an Equatorial or Axial β-Position to the Amino GroupPatrick Schnider, Cosimo Dolente, Henri Stalder, et al.
Nature Reviews. Drug Discovery|July 31, 2010
Coexistence of passive and carrier-mediated processes in drug transportKiyohiko Sugano, Manfred Kansy, Per Artursson, et al.
BMC Cancer|July 15, 2015
Prospective cohort study using the breast cancer spheroid model as a predictor for response to neoadjuvant therapy--the SpheroNEO studyKathrin Halfter, Nina Ditsch, Hans-Christian Kolberg, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitorsEmmanuel Pinard, Daniela Alberati, Edilio Borroni, et al.
Drug Discovery Today|April 18, 2012
Evidence-based approach to assess passive diffusion and carrier-mediated drug transportLi Di, Per Artursson, Alex Avdeef, et al.
Bioorganic & Medicinal Chemistry Letters|September 19, 2009
The discovery and unique pharmacological profile of RO4938581 and RO4882224 as potent and selective GABAA alpha5 inverse agonists for the treatment of cognitive dysfunctionHenner Knust, Guido Achermann, Theresa Ballard, et al.
Pageof 7